Araştırma Makalesi
BibTex RIS Kaynak Göster

The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients

Yıl 2021, Cilt: 48 Sayı: 4, 754 - 760, 01.12.2021
https://doi.org/10.5798/dicletip.1037628

Öz

Kaynakça

  • 1.Leitner DR, Frühbeck G, Yumuk V, et al. Obesityand type 2 diabetes:Two diseases with a need forcombined treatment strategies-EASO can lead theway. Obes Facts. 2017; 10: 483-92.
  • 2.Rueda- Clausen CF, Ogunleye AA, Sharma AM.Health benefits of long-term weight-lossmaintenance. Annu Rev Nutr. 2015; 35: 475-516
  • 3.Flegal KM, Carroll MD, Ogden CL, Johnson CL.Prevalence and trends in obesity among US adults,1999-2000. JAMA. 2002; 288: 1723-7.

The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients

Yıl 2021, Cilt: 48 Sayı: 4, 754 - 760, 01.12.2021
https://doi.org/10.5798/dicletip.1037628

Öz

Objective: To examine the association of weight loss achieved through obesity treatment with platelet number and markers (mean platelet volume, MPV; plateletcrit, PCT; platelet/lymphocyte ratio, PLR; and platelet distribution width, PDW) in morbidly obese patients.
Methods: A total of 300 patients diagnosed with morbid obesity between 2017 and 2019 were included in this retrospective study. Weight at baseline and 6 months, body mass index (BMI), complete blood count (platelet, lymphocyte, plateletcrit, platelet/lymphocyte ratio, and platelet distribution width), and demographic data were evaluated.
Results: A total of 300 morbidly obese patients with a BMI ≥ 40 kg/m2 were included. A weight loss of ≥ 10% was considered “significant”, and a weight loss of < 10% was considered insignificant. A significant decrease in platelet number was found in association with weight loss (p < 0.05), as were the changes in PCT and PLR. These findings suggest that platelet markers PCT and PLR may be associated with the degree of weight loss.
Conclusion: Our results suggest that platelet markers simply obtained through a complete blood count may be utilized in the treatment and follow-up of obesity, which may lead to a number of different conditions such as coronary artery disease, cerebrovascular events, and myocardial infarction through predisposition to thrombosis.

Kaynakça

  • 1.Leitner DR, Frühbeck G, Yumuk V, et al. Obesityand type 2 diabetes:Two diseases with a need forcombined treatment strategies-EASO can lead theway. Obes Facts. 2017; 10: 483-92.
  • 2.Rueda- Clausen CF, Ogunleye AA, Sharma AM.Health benefits of long-term weight-lossmaintenance. Annu Rev Nutr. 2015; 35: 475-516
  • 3.Flegal KM, Carroll MD, Ogden CL, Johnson CL.Prevalence and trends in obesity among US adults,1999-2000. JAMA. 2002; 288: 1723-7.
Toplam 3 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Original Articles
Yazarlar

Gamze Öztürk Bu kişi benim

Müzeyyen Aslaner Ak Bu kişi benim

Sehmus Ertop Bu kişi benim

Yayımlanma Tarihi 1 Aralık 2021
Gönderilme Tarihi 9 Ağustos 2021
Yayımlandığı Sayı Yıl 2021 Cilt: 48 Sayı: 4

Kaynak Göster

APA Öztürk, G., Aslaner Ak, M., & Ertop, S. (2021). The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients. Dicle Medical Journal, 48(4), 754-760. https://doi.org/10.5798/dicletip.1037628
AMA Öztürk G, Aslaner Ak M, Ertop S. The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients. diclemedj. Aralık 2021;48(4):754-760. doi:10.5798/dicletip.1037628
Chicago Öztürk, Gamze, Müzeyyen Aslaner Ak, ve Sehmus Ertop. “The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients”. Dicle Medical Journal 48, sy. 4 (Aralık 2021): 754-60. https://doi.org/10.5798/dicletip.1037628.
EndNote Öztürk G, Aslaner Ak M, Ertop S (01 Aralık 2021) The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients. Dicle Medical Journal 48 4 754–760.
IEEE G. Öztürk, M. Aslaner Ak, ve S. Ertop, “The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients”, diclemedj, c. 48, sy. 4, ss. 754–760, 2021, doi: 10.5798/dicletip.1037628.
ISNAD Öztürk, Gamze vd. “The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients”. Dicle Medical Journal 48/4 (Aralık 2021), 754-760. https://doi.org/10.5798/dicletip.1037628.
JAMA Öztürk G, Aslaner Ak M, Ertop S. The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients. diclemedj. 2021;48:754–760.
MLA Öztürk, Gamze vd. “The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients”. Dicle Medical Journal, c. 48, sy. 4, 2021, ss. 754-60, doi:10.5798/dicletip.1037628.
Vancouver Öztürk G, Aslaner Ak M, Ertop S. The Association Between Weight Loss and Platelet Markers in Morbidly Obese Patients. diclemedj. 2021;48(4):754-60.